The effects of gender and obesity on myocardial tolerance to ischemia

Physiological Research

Volumn 60, Issue 2, 2011, Pages 291-301

  Clark, C ^a   Smith, W ^a   Lochner, A ^a   Toit, E F Du ^b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

Gender; Myocardial infarction; Obesity

Indexed keywords

EID: 79959255409     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.931999     Document Type: Article

References (58)

1. AUBIN MC, LAJOIE C, CLEMENT R, GOSSELIN H, CALDERONE A, PERRAULT LP: Female rats fed a high-fat diet were associated with vascular dysfunction and cardiac fibrosis in the absence of overt obesity and hyperlipidemia: Therapeutic potential of resveratrol. J Pharmacol Exp Ther 325: 961-968, 2008.
2. BAE S, ZHANG L: Gender differences in cardioprotection against ischemia/reperfusion injury in adult rat hearts: Focus on Akt and protein kinase C signaling. J Pharmacol Exp Ther 315: 1125-1135, 2005.
3. BARRETT-CONNOR E: Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation 95: 252-264, 1997.
4. BATTERHAM RL, COWLEY MA, SMALL CJ, HERZOG H, COHEN MA, DAKIN CL, WREN AM, BRYNES AE, LOW MJ, GHATEI MA, CONE RD, BLOOM SR: Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654, 2002.
5. BERG AH, COMBS TP, DU X, BROWNLEE M, SCHERER PE: The adipocyte secreted protein Acrp30 enhances hepatic insulin action. Nature Med 7: 947-953, 2001.
6. BJÖRNTORP P: Visceral obesity: a "civilization syndrome" . Obesity Res 3: 206-222, 1993.
7. BODEN G, SHULMAN GI: Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur J Clin Invest 32: 14-23, 2002.
8. BOURNE LT, LAMBERT EV, STEYN K: Where does the black population of South Africa stand on the nutrition transition? Public Health Nutr 5: 157-162, 2002
9. COATMELLEC-TAGLIONI G, DAUSSE JP, GIUDICELLI Y, RIBIÈRE C: Sexual dimorphism in cafeteria dietinduced hypertension is associated with gender-related difference in renal leptin receptor down-regulation. J Pharmacol Exp Ther 305: 362-367, 2003.
10. COMBS TP, BERG AH, OBICI S, SCHERER PE, ROSSETTI L: Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108: 1875-1881, 2001.
11. CORDERO A, LEÓN M, ANDRÉS E, ORDOÑEZ B, LACLAUSTRA M, GRIMA A, PASCUAL I, LUENGO E, CIVEIRA F, POCOVÍ M, ALEGRÍA E, CASASNOVAS JA: MESYAS Registry investigators. Gender differences in obesity related cardiovascular risk factors in Spain. Prev Med 48: 134-139, 2009.
12. COSTACOU T, ZGIBOR JC, EVANS RW, OTVOS J, LOPES-VIRELLA MF, TRACY RP, ORCHARD TJ: The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 48: 41-48, 2005.
13. CRABBE DL, DIPLA K, AMBATI S, ZAFEIRIDIS D: Gender differences in post-infarction hypertrophy in end-stage failing hearts. J Am Coll Cardiol 41: 300-306, 2003.
14. CROSS H, LU L, STEENBERGEN C, PHILIPSON K, MURPHY E: Overexpression of the cardiac Na+/Ca2+ exchanger increases susceptibility to ischemia/reperfusion injury in male, but not female, transgenic mice. Circ Res 83: 1215-1223, 1998.
15. CROSS H, KRANIAS E, MURPHY E, STEENBERGEN C: Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: protective role of NO. Am J Physiol 284: H683-H690, 2003.
16. 2+ loading and adrenergic stimulation reveal male/female differences in susceptibility to ischemia-reperfusion injury. Am J Physiol 283: H481-H489, 2002.
17. DU TOIT EF, NABBEN M, LOCHNER A: A potential role for Angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury. Basic Res Cardiol 100: 346-354, 2005.
18. DU TOIT EF, SMITH W, MULLER C, STRIJDOM H, STOUTHAMMER B, WOODIWISS AJ, NORTON GR, LOCHNER A: Myocardial susceptibility to ischemic-reperfusion injury in a prediabetic model of dietaryinduced obesity. Am J Physiol 294: H2336-H2343, 2008.
19. FERDINANDY P, SZILVÁSSY Z, HORVÁTH LI, CSONT T, CSONKA C, NAGY E, SZENTGYÖRGYI R, NAGY I, KOLTAI M, DUX L: Loss of pacing-induced preconditioning in rat hearts: role of nitric oxide and cholesterol-enriched diet. J Mol Cell Cardio 29: 3321-3333, 1997.
20. FERRARA CM, GOLDBERG AP, NICKLAS BJ, SORKIN JD, RYAN AS: Sex differences in insulin action and body fat distribution in overweight and obese middle-aged and older men and women. Appl Physiol Nutr Metab 33: 784-790, 2008.
21. FRUEBIS J, TSAO TS, JAVORSCHI S, EBBETS-REED D, ERICKSON MR, YEN FT, BIHAIN BE, LODISH HF: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98: 2005-2010, 2001.
22. GABEL SA, WALKER VR, LONDON RE, STENBERGEN C, KORACH KS, MURPHY E: Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J Mol Cell Cardiol 38: 289-297, 2005.
23. GÓMEZ-PÉREZ Y, AMENGUAL-CLADERA E, CATALÀ-NIELL A, THOMÀS-MOYÀ E, GIANOTTI M, PROENZA AM, LLADÓ I : Gender dimorphism in high-fat-diet-induced insulin resistance in skeletal muscle of aged rats. Cell Physiol Biochem 22: 539-548, 2008.
24. GROHNÉ C, KAHLERT S, LÖBBERT K, VETTER H: Expression of oestrogen receptor α and β in the rat heart: role of local oestrogen synthesis. J Endocrinol 156: R1-R7, 1998.
25. HAYWARD CS, KELLY RP, COLLINS P: The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46: 28-49, 2000.
26. HORTON TJ, GAYLES EC, PRACH PA, KOPPENHAFER TA, PAGLIASSOTTI MJ: Female rats do not develop sucrose-induced insulin resistance. Am J Physiol 272: R1571-R1576, 1997.
27. KENCHAIAH S, EVANS JC, LEVY D, WILSON PWF, BENJAMIN EJ, LARSON MG, KANNEL WB, VASAN RS: Obesity and the risk of heart failure. New Eng J Med 347: 305-313, 2002.
28. KHAN MK, BOWMAN B: Obesity: a major public health problem. Annual Review of Nutrition 19: xiii-xvii, 1999.
29. KRAEGEN EW, CLARK PW, JENKINS AB, DALEY EA, CHISHOLM DJ, STORLIEN LH: Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397-1403, 1991.
30. KRUGER HS, PUOANE T, SENEKAL M, VAN DER MERWE MT: Obesity in South Africa: challenges for government and health professionals. Public Health Nutr 8: 491-500, 2005.
31. KUBOTA N, TERAUCHI Y, YAMAUCHI T, KUBOTA T, MOROI M, MATSUI J, ETO K, YAMASHITA T, KAMON J, SATOH H, YANO W, FROGUEL P, NAGAI R, KIMURA S, KADOWAKI T, NODA T: Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277: 25863-25866, 2002.
32. LOPASCHUK GD, FOLMES CDL, STANLEY WC: Cardiac energy metabolism in obesity. Circ Res 101: 335-347, 2007.
33. LOPASCHUK GD, REBEYKA IM, ALLARD MF: Metabolic modulation: a means to mend a broken heart. Circulation 105: 140-142, 2002.
34. LOUET JF, LEMAY C, MAUVAIS-JARVIS F: Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep 6: 180-185, 2004.
35. MACINTYRE UE, KRUGER HS, VENTER CS, VORSTER HH: Dietary intake of an African population in different stages of transition in the North West Province, South Africa, the THUSA study. Nutrition Research 22: 239-256, 2002.
36. MEHELLI J, KASTRATI A, DIRSCHINGER J, PACHE J, SEYFARTH M, BLASINI R, HALL D, NEUMANN FJ, SCHOMIG A: Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. J Am Med Assoc 287: 210-215, 2002.
37. MOSCA L, BANKA CL, BENJAMIN EJ, BERRA K, BUSHNELL C, DOLOR RJ, GANIATS TG, GOMES AS, GORNIK HL, GRACIA C, GULATI M, HAAN CK, JUDELSON DR, KEENAN N, KELEPOURIS E, MICHOS ED, NEWBY LK, OPARIL S, OUYANG P, OZ MC, PETITTI D, PINN VW, REDBERG RF, SCOTT R, SHERIF K, SMITH SC JR, SOPKO G, STEINHORN RH, STONE NJ, TAUBERT KA, TODD BA, URBINA E, WENGER NK: Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 115: 1481-501, 2007.
38. rd Edition. Raven Press, Philadelphia, NY, Chapter 11, 1998, pp 295-342.
39. PEDERSEN SB, KRISTENSEN K, HERMANN PA, KATZENELLENBOGEN JA, RICHELSEN B: Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab 89: 1869-1878, 2004.
40. PICKAVANCE L, TADAYYON M, WIDDOWSON PS, BUCKINGHAM RE, WILDING JP: Therapeutic index for rosiglitazone in dietary obese rats: separation of efficacy and haemodilution. Br J Pharmacol 128: 1570-1576, 1999.
41. POIRIER P, GILES TD, BRAY GA, HONG Y, STERN JS, PI-SUNYER FX, ECKEL RH: Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. American Heart Association; Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 113: 898-918, 2006.
42. + channels. J Am Coll Cardiol 38: 906-915, 2001.
43. REGITZ-ZAGROSEK V, LEHMKUHL E, MAHMOODZADEH S: Gender aspects of the role of the metabolic syndrome as a risk factor for cardiovascular disease. Gend Med 4: S162-S177, 2007.
44. RINCON J, HOLMÄNG A, WAHLSTRÖM EO, LÖNNROTH P, BJÖRNTORP P, ZIERATH JR, WALLBERGHENRIKSSON H: Mechanisms behind insulin resistance in rat skeletal muscle after oophorectomy and additional testosterone treatment. Diabetes 45: 615-621, 1996.
45. ROACH PD, BALASUBRAMANIAM S, HIRATA F, ABBEY M, SZANTO A, SIMONS LA, NESTEL PJ: The lowdensity lipoprotein receptor and cholesterol synthesis are affected differently by dietary cholesterol in the rat. Biochim Biophys Acta 1170: 165-172, 1993.
46. ROSSOUW JE, ANDERSON GL, PRENTICE RL, LACROIX AZ, KOOPERBERG C, STEFANICK ML: Risk and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288: 321-333, 2002.
47. RYO M, NAKAMURA T, KIHARA S, KUMADA M, SHIBAZAKI S, TAKAHASHI M, NAGAI M, MATSUZAWA Y, FUNAHASHI T: Adiponectin as a biomarker of the metabolic syndrome. Circ J 68: 975-981, 2004.
48. SOWERS JR: Obesity as a cardiovascular risk factor. Am J Med 115: 37S-40S, 2003.
49. STEFAN N, VOZAROVA B, FUNAHASHI T, MATSUZAWA Y, WEYER C, LINDSAY RS, YOUNGREN JF, HAVEL J, PRATLEY RE, BOGARDUS C, TATARANNI A: Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 50: 1884-1888, 2002.
50. THAKKER GD, FRANGIOGIANNIS NG, BUJAK M, ZYMEK P, GAUBATZ JW, REDDY AK, TAFFET G, MICHAEL LH, ENTMANN ML, BALANTYNE CM: Effect of diet induced obesity on inflammation and remodeling after myocardial infarction. Am J Physiol Heart Circ Physiol 291: H2504-H2514, 2006.
51. THIM T, BENTZON JF, KRISTIANSEN SB, SIMONSEN U, ANDERSEN HL, WASSERMANN K, FALK E: Size of myocardidal infarction induced by ischaemia/reperfusion is unaltered in rats with metabolic syndrome. Clin Sci 110: 665-671, 2006.
52. TURNER N, BRUCE CR, BEALE SM, HOEHN KL, SO T, ROLPH MS, COONEY GJ: Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56: 2085-2092, 2007.
53. TUUNANEN H, ENGBLOM E, NAUM A, KJELL N, HESSE B, AIRAKSINEN J, NUUTILA P, IZZO P, UKKONEN H, OPIE LH, KNUUTI J: Free fatty acid deleption acutely decreases cardiac work and efficiency in cardiomyopathic heart failure. Circulation 114: 130-2137, 2006.
54. VISTISEN B, HELLGREN LI, VADSET T, SCHEEDE-BERGDAHL C, HELGE JW, DELA F, STALLKNECHT B: Effect of gender on lipid-induced insulin resistance in obese subjects. Eur Endocrinol 158: 61-68, 2008.
55. WALLHAUS TR, TAYLOR M, DEGRADO TR, RUSSELL DC, STANKO P, NICKLES RJ, STONE CK: Myocardial free fatty acid and glucose used after carvedilol treatment in patients with congestive heart failure. Circulation 103: 2441-2446, 2001.
56. WANG M, CRISOSTOMO P, WAIRIUKO GM, MELDRUM DR: Estrogen receptor-alpha mediates acute myocardial protection in females. Am J Physiol 290: H2204-H2209, 2006.
57. YAMAUCHI T, JAMON J, WAKE H, TERAUCHI Y, KUBOTA N, HARA K, MORI Y, IDE T, MURAKAMI K, TSUBOYANA-KASAOKA N, EZAKI O, AKANUMA Y, GAVRILOVA O, VINSON C, REITMAN ML, KAGECHIKA H, SHUDO K, YODA M, NAKANO Y, TOBE K, NAGAI R, KIMURA S, TOMITA M, FROGUEL P, KADOWAKI T: The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med 7: 941-946, 2001.
58. YUSUF S, HAWKEN S, OUNPUU S, BAUTISTA L, FRANZOSI MG, COMMERFORD P, LANG CC, RUMBOLDT Z, ONEN CL, LISHENG L, TANOMSUP S, WANGAI P, RAZAK F, SHARMA AM, ANAND S: Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: A case control study. Lancet 366: 1640-1649, 2005.